These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21376690)

  • 21. Visceral leishmaniasis in a renal transplant recipient. Short review and therapy alternative.
    Gómez Campderá F; Berenguer J; Anaya F; Rodriguez M; Valderrábano F
    Am J Nephrol; 1998; 18(2):171. PubMed ID: 9569963
    [No Abstract]   [Full Text] [Related]  

  • 22. Visceral leishmaniasis in renal transplant recipients: successful treatment with liposomal amphotericin B (AmBisome).
    Boletis JN; Pefanis A; Stathakis C; Helioti H; Kostakis A; Giamarellou H
    Clin Infect Dis; 1999 Jun; 28(6):1308-9. PubMed ID: 10451172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-transplant lymphoproliferative disorder after kidney transplantation: time to adopt monitoring of Epstein-Barr virus?
    Biller P; Michaux L; Pauw LD; Camboni A; Mourad M; Kanaan N
    Acta Clin Belg; 2015 Jun; 70(3):218-22. PubMed ID: 25541210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meglumine antimoniate-induced pancreatitis.
    Torrús D; Massa B; Boix V; Portilla J; Pérez-Mateo M
    Am J Gastroenterol; 1996 Apr; 91(4):820-1. PubMed ID: 8677970
    [No Abstract]   [Full Text] [Related]  

  • 25. Leishmaniasis: a rare cause of unexplained fever in a renal graft recipient.
    Moulin B; Ollier J; Bouchouareb D; Purgus R; Olmer M
    Nephron; 1992; 60(3):360-2. PubMed ID: 1565190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
    Tai CC; Curtis JL; Szmuszkovicz JR; Horn MV; Ford HR; Woo MS; Wang KS
    J Pediatr Surg; 2008 Dec; 43(12):2174-7. PubMed ID: 19040929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Post-transplant lymphoproliferative disorders in renal transplantation: two decades of experience].
    Franco A; Jiménez L; Sillero C; Trigueros M; González D; Alcaraz E; Olivares J
    Nefrologia; 2010; 30(6):669-75. PubMed ID: 21113217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visceral leishmaniasis in a renal transplant recipient treated with allopurinol.
    Harzallah K; Belhadj R; Jemli B; Haloues M; Berraies N; Gargouri S; Hmida J; Battikh R; Manaa J
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):105-8. PubMed ID: 20061702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sirolimus-induced remission of posttransplantation lymphoproliferative disorder.
    Cullis B; D'Souza R; McCullagh P; Harries S; Nicholls A; Lee R; Bingham C
    Am J Kidney Dis; 2006 May; 47(5):e67-72. PubMed ID: 16632009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case.
    Gomes MAF; Medeiros LLC; Lobo FPD; Wanderley NRS; Matos APR; Jácome TDN; Monteiro MGL; Luz KG
    Rev Soc Bras Med Trop; 2018; 51(3):393-396. PubMed ID: 29972577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visceral Leishmaniasis in Renal Transplant Recipients: Report of 2 Cases.
    Clavijo Sánchez F; Vázquez Sánchez T; Cabello Díaz M; Sola Moyano VE; Jironada Gallego C; Hernández Marrero D
    Transplant Proc; 2018 Mar; 50(2):581-582. PubMed ID: 29579858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visceral leishmaniasis after kidney transplantation: report of a new case and a review of the literature.
    Bouchekoua M; Trabelsi S; Ben Abdallah T; Khaled S
    Transplant Rev (Orlando); 2014 Jan; 28(1):32-5. PubMed ID: 24321305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subacute immune response to primary EBV infection leading to post-transplant lymphoproliferative disease in a renal transplant patient.
    Leaver S; Amlot P; Thuraisingham R; Norton A; Aitken C; Cavenagh JD
    Clin Lab Haematol; 2004 Oct; 26(5):351-3. PubMed ID: 15485466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary re-occurrence of post-transplant lymphoproliferative disease with hypogammaglobulinaemia.
    Wolf MTF; Mildenberger E; Lennert T; Anagnostopoulos I; Zinn C; Paul K; Keitzer R; Versmold H
    Eur J Pediatr; 2003 Mar; 162(3):180-183. PubMed ID: 12655423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder.
    Davis CL; Harrison KL; McVicar JP; Forg PJ; Bronner MP; Marsh CL
    Clin Transplant; 1995 Feb; 9(1):53-9. PubMed ID: 7742583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early antimoniate poisoning in a non-fatal visceral leishmaniasis kidney transplant recipient with renal failure.
    Esteban RJ; Bravo JA; Osuna A; Asensio C
    Nephrol Dial Transplant; 1996 Sep; 11(9):1898. PubMed ID: 8918659
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of visceral leishmaniasis with liposomal amphotericin B in three immunocompromised patients].
    Rodríguez-Wilhelmi P; Panizo C; Ruza E; Rocha E
    Med Clin (Barc); 2001 Jan; 116(1):37-8. PubMed ID: 11181264
    [No Abstract]   [Full Text] [Related]  

  • 38. Concomitant BK virus infection and visceral Leishmaniasis in a pediatric liver transplant recipient.
    Derakhshan D; Basiratnia M; Derakhshan A; Fallahzadeh MH; Dehghani SM; Soleimani N; Anbardar MH; Shirazi Yeganeh B; Mohammadzadeh S
    Pediatr Transplant; 2021 Dec; 25(8):e14100. PubMed ID: 34302419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of intraocular post-transplant lymphoproliferative disorder with intravenous rituximab.
    Iu LP; Yeung JC; Loong F; Chiang AK
    Pediatr Blood Cancer; 2015 Jan; 62(1):169-72. PubMed ID: 25174958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Virus, immunosuppression, and the kidney transplant recipient].
    Alberú J; Villasís A
    Rev Invest Clin; 2005; 57(4):582-95. PubMed ID: 16315643
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.